Mark Fisher

Summary

Publications

  1. doi request reprint Cost-effectiveness of trabectedin plus pegylated liposomal doxorubicin for the treatment of women with relapsed platinum-sensitive ovarian cancer in the UK: analysis based on the final survival data of the OVA-301 trial
    Mark Fisher
    WG Consulting, High Wycombe, UK
    Value Health 16:507-16. 2013

Detail Information

Publications1

  1. doi request reprint Cost-effectiveness of trabectedin plus pegylated liposomal doxorubicin for the treatment of women with relapsed platinum-sensitive ovarian cancer in the UK: analysis based on the final survival data of the OVA-301 trial
    Mark Fisher
    WG Consulting, High Wycombe, UK
    Value Health 16:507-16. 2013
    ....